Rebekka K. Schneider: Our research will be supported by an European Research Council (ERC) consolidator grant
Rebekka K. Schneider, Director of the Institute of Cell and Tumor Biology at Uniklinik RWTH Aachen, shared a post by European Reseach Council, on LinkedIn, adding:
“Incredibly grateful and extremely excited to announce that our research at schneiderlab.org will be supported by an European Research Council (ERC) consolidator grant to unravel mechanisms of fibrosis reversal and identify novel therapeutic anti-fibrotic targets in patients with MPN and fibrosis. This would not be possible without many wonderful collaboration partners, in particular Ivan Gesteira Costa Filho Tim Brümmendorf and Martina Crysandt, an amazing team Uniklinik RWTH Aachen RWTH Aachen University Erasmus MC. Let’s continue our fight against fibrosis and hopefully translate our findings into improved clinical settings with Oncode Institute, Sequantrix GmbH.”
Quoting European Reseach Council‘s post:
“The results of the 2023 ERC Consolidator Grant competition are out. €627 million for 308 researchers
Who has been offered ERCCoG funding? What topics and questions will they investigate? Where will they conduct their research? Answers revealed today.”
For details click here.
Source: Rebekka K. Schneider/LinkedIn and European Research Council/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023